Cabaletta Bio Inc (NASDAQ:CABA) price on Wednesday, April 17, fall -7.00% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $15.15.
A look at the stock’s price movement, the close in the last trading session was $16.29. Turning to its 52-week performance, $26.35 and $7.69 were the 52-week high and 52-week low respectively. Overall, CABA moved -15.74% over the past month.
Cabaletta Bio Inc’s market cap currently stands at around $649.18 million. Analysts project the company’s earnings per share (EPS) to be -$0.48, which has seen fiscal year 2024 EPS growth forecast to increase to -$1.9 and about -$2.09 for fiscal year 2025. Per the data, EPS growth is expected to be -15.20% for 2024 and -10.00% for the next financial year.
Analysts have a consensus estimate of -$ for the company’s revenue for the quarter, with a low and high estimate of -$ and -$ respectively.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was — upward and — downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that CABA is a 100% Sell. On the other hand, the stock is on average a 25% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
CABA’s current price about -11.90% and -25.54% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 31.77, while 7-day volatility ratio is 7.01% and 6.51% in the 30-day chart. Further, Cabaletta Bio Inc (CABA) has a beta value of 2.41, and an average true range (ATR) of 1.19.
If we refocus on Cabaletta Bio Inc (NASDAQ:CABA), historical trading data shows that trading volumes averaged 947.92K over the past 3 months. The company’s latest data on shares outstanding shows there are 47.82 million shares.
The 18.86% of Cabaletta Bio Inc’s shares are in the hands of company insiders while institutional holders own 96.32% of the company’s shares. Current price change has pushed the stock -33.26% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CABA stock continues to rise going into the next quarter.